Loukia Vassilopoulou

Mrs. Loukia Vassilopoulou

Internal Medicine, The General Hospital of Heraklion "Venizeleio-Pananio", Heraklion, Greece
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
DPDemetrios Petrakis
Demetrios Petrakis
Loukia VassilopoulouLoukia Vassilopoulou
Loukia Vassilopoulou
CHARALAMPOS MAMOULAKISCHARALAMPOS MAMOULAKIS
CHARALAMPOS MAMOULAKIS
CPChristos Psycharakis
Christos Psycharakis
AAAliki Anifantaki
Aliki Anifantaki
Aristidis TsatsakisAristidis Tsatsakis
Aristidis Tsatsakis
The review aims to comprehensively present the impact of exposure to endocrine disruptors (EDs) in relation to the clinical manifestation of obesity and related diseases, including diabetes mellitus, metabolic syndrome, cardiovascular diseases, carcinogenesis and infertility. EDs are strong participants in the obesity epidemic scenery by interfering with cellular morphological and biochemical processes; by inducing inflammatory responses; and by presenting transcriptional and oncogenic activity. Obesity and lipotoxicity enhancement occur through reprogramming and/or remodeling of germline epigenome by exposure to EDs. Specific population groups are vulnerable to ED exposure due to current dietary and environmental conditions. Obesity, morbidity and carcinogenicity induced by ED exposure are an evolving reality. Therefore, a new collective strategic approach is deemed essential, for the reappraisal of current global conditions pertaining to energy management.

4 September 2023 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
SKStamatis Karakonstantis
Stamatis Karakonstantis
MRMaria Rousaki
Maria Rousaki
Loukia VassilopoulouLoukia Vassilopoulou
Loukia Vassilopoulou
Evangelos I. KritsotakisEvangelos I. Kritsotakis
Evangelos I. Kritsotakis

1 January 2018 in Toxicology Reports
Verified
Journal Article
Open access
Aristidis TsatsakisAristidis Tsatsakis
Aristidis Tsatsakis
Loukia VassilopoulouLoukia Vassilopoulou
Loukia Vassilopoulou
LKL. Kovatsi
L. Kovatsi
Christina TsitsimpikouChristina Tsitsimpikou
Christina Tsitsimpikou
MKM. Karamanou
M. Karamanou
DSD.A. Spandidos
D.A. Spandidos
Since ancient times the concept of dose response, from a toxicological perspective, has been a matter of concern. Already by the 8th century BC and over the years, many enlightened people have attempted to interpret this phenomenon, observing and coming across its results and practical implementation through exposure to chemical substances, either from natural or synthetic sources. Nowadays, the environmental exposure of human populations to chemicals in terms of quantity and quality might differ. Nevertheless, dose response still remains an issue joining hands with scientific and technological progress. The aim of the present review is not only to briefly recount the history of the dose response concept, from ancient time theories to novel approaches, but also to draw the outline of challenges and requirements toxicology science needs to fulfill.

21 March 2018 in Oncology Reports
Verified
Journal Article
Open access
PDF file
TNTaxiarchis Konstantinos Nikolouzakis
Taxiarchis Konstantinos Nikolouzakis
Loukia VassilopoulouLoukia Vassilopoulou
Loukia Vassilopoulou
PFPersefoni Fragkiadaki
Persefoni Fragkiadaki
TSTheodoros Mariolis Sapsakos
Theodoros Mariolis Sapsakos
GPGeorgios Z. Papadakis
Georgios Z. Papadakis
JTJohn Tsiaoussis
John Tsiaoussis
Colorectal cancer (CRC) is among the most common cancers. In fact, it is placed in the third place among the most diagnosed cancer in men, after lung and prostate cancer, and in the second one for the most diagnosed cancer in women, following breast cancer. Moreover, its high mortality rates classifies it among the leading causes of cancer‑related death worldwide. Thus, in order to help clinicians to optimize their practice, it is crucial to introduce more effective tools that will improve not only early diagnosis, but also prediction of the most likely progression of the disease and response to chemotherapy. In that way, they will be able to decrease both morbidity and mortality of their patients. In accordance with that, colon cancer research has described numerous biomarkers for diagnostic, prognostic and predictive purposes that either alone or as part of a panel would help improve patient's clinical management. This review aims to describe the most accepted biomarkers among those proposed for use in CRC divided based on the clinical specimen that is examined (tissue, faeces or blood) along with their restrictions. Lastly, new insight in CRC monitoring will be discussed presenting promising emerging biomarkers (telomerase activity, telomere length and micronuclei frequency).

1 January 2017 in Toxicology Reports
Verified
Journal Article
Open access
Anca Oana DoceaAnca Oana Docea
Anca Oana Docea
Loukia VassilopoulouLoukia Vassilopoulou
Loukia Vassilopoulou
DFDomniki Fragou
Domniki Fragou
AAAndreea Letitia Arsene
Andreea Letitia Arsene
CFConcettina Fenga
Concettina Fenga
Nikolaos DrakoulisNikolaos Drakoulis
Nikolaos Drakoulis
The association between genetic variations in the cytochrome P450 (CYP) family genes and pathological conditions related to long-term exposure to organochlorine compounds (OCs) deserves further elucidation. OCs are persistent organic pollutants with bioaccumulative and lipophilic characteristics. They can act as endocrine disruptors and perturb cellular mechanisms. Prolonged exposure to OCs has been associated with different pathological manifestations. CYP genes are responsible for transcribing enzymes essential in xenobiotic metabolism. Therefore, polymorphisms in these genetic sequences a. alter the metabolic pathways, b. induce false cellular responses, and c. may provoke pathological conditions. The main aim of this review is to define the interaction between parameters a, b and c at a mechanistic/molecular level, with references in clinical cases.

1 December 2017 in Environmental Toxicology and Pharmacology
Verified
Journal Article
Closed access
SVSlavica Vučinić
Slavica Vučinić
BABiljana Antonijevic
Biljana Antonijevic
Aristidis TsatsakisAristidis Tsatsakis
Aristidis Tsatsakis
Loukia VassilopoulouLoukia Vassilopoulou
Loukia Vassilopoulou
Anca Oana DoceaAnca Oana Docea
Anca Oana Docea
DBDragica Brkic
Dragica Brkic